Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01390636 · ClinicalTrials.gov registry record
Type 1 Diabetes and Eating Disorder Diurnal Glucose Patterns
A clinical trial, sponsored by HealthPartners Institute.
- Terminated
- Registry status
- 1
- Enrollment target
NCT01390636: Clinical Trial study, sponsored by HealthPartners Institute.
NCT01390636 is a clinical trial that was terminated before completion, run by HealthPartners Institute. The registered enrollment target is 1 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01390636 was terminated before completion, sponsored by HealthPartners Institute.
- TERMINATED
- Registry status
- 1 participants
- Enrollment target
Study Summary
The purpose of this study is to use data from the Continuous Glucose Monitor (CGM) to determine the degree of variation in glucose levels of individuals with an eating disorder and type 1 diabetes and only an eating disorder.
Primary Outcome
Determine the degree of variation in glycemic profiles of individuals with ED-DMT1 and ED/only using Continuous Glucose Monitoring (CGM). CGM will be graphically and statistically represented by an Ambulatory Glucose Profile (AGP).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2011-07 |
| Est. Completion | 2013-05 |
Why NCT01390636 stopped before completion
NCT01390636 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 1 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT01390636 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01390636 about?
NCT01390636 is a clinical study titled "Type 1 Diabetes and Eating Disorder Diurnal Glucose Patterns". The purpose of this study is to use data from the Continuous Glucose Monitor (CGM) to determine the degree of variation in glucose levels of individuals with an eating disorder and type 1 diabetes and only an eating disorder.
What is the current status of trial NCT01390636?
This trial is currently terminated. The enrollment target is 1 participants. The study started on 2011-07. Estimated completion is 2013-05.
Who is sponsoring clinical trial NCT01390636?
This trial is sponsored by HealthPartners Institute, which has 146 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia